Insights

Market Access Focus PRO-spectus specializes in Patient Support Services, Market Access, Reimbursement Support, and Policy Strategy, indicating strong cross-selling opportunities with pharmaceutical manufacturers, medical device firms, and diagnostic companies seeking to expand product access and payer coverage.

Growth Potential Revenue range of 100M to 250M and recent private equity acquisition by Shore Capital Partners suggest a growth-oriented environment with potential for scale-focused partnerships, additional services expansion, and co-marketing opportunities.

Talent Transformation New Chief People & Culture Officer appointed in January 2025 signals a focus on organizational development and leadership capability, presenting opportunities to align sales messaging around culture, change management, and client implementation success.

Tech Enablement Adoption of technology and analytics tools such as Sage Intacct, Tableau, Microsoft 365, and Adobe Experience Cloud points to a data-driven service delivery model; potential upsell of advanced analytics, reporting, and automated patient-support workflows.

Expansion Readiness Recent PE investment and the company’s positioning to expand access across the care continuum indicate readiness for multi-market expansion, cross-border patient access programs, and strategic partnerships with life sciences clients seeking broader payer and policy strategy support.

Similar companies to PRO-spectus

PRO-spectus Tech Stack

PRO-spectus uses 8 technology products and services including Sage Intacct, Tableau, Lucidchart, and more. Explore PRO-spectus's tech stack below.

PRO-spectus's Email Address Formats

PRO-spectus uses at least 1 email format:
PRO-spectus Email FormatsExamplePercentage
FLast@pro-spectus.comJDoe@pro-spectus.com
100%

Frequently Asked Questions

What is PRO-spectus's official website and social media links?

Minus sign iconPlus sign icon
PRO-spectus's official website is pro-spectus.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does PRO-spectus generate?

Minus sign iconPlus sign icon
As of August 2026, PRO-spectus's annual revenue is estimated to be $100M - $250M.

What is PRO-spectus's SIC code and NAICS code?

Minus sign iconPlus sign icon
PRO-spectus's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does PRO-spectus have currently?

Minus sign iconPlus sign icon
As of August 2026, PRO-spectus has approximately 130 employees across 4 continents, including North America, Asia and Europe. Key team members include Chief Executive Officer: O. M., Vice President Of Pharmacy And Clinical Solutions, Market Access: J. N. and Lead Independent Director: M. J. Explore PRO-spectus's employee directory with LeadIQ.

What industry does PRO-spectus belong to?

Minus sign iconPlus sign icon
PRO-spectus operates in the Pharmaceutical Manufacturing industry.

What technology does PRO-spectus use?

Minus sign iconPlus sign icon
PRO-spectus's tech stack includes Sage Intacct, Tableau, Lucidchart, WordPress, CookieYes, Adobe Experience Cloud, Microsoft 365 and Salesloft.

What is PRO-spectus's email format?

Minus sign iconPlus sign icon
PRO-spectus's email format typically follows the pattern of FLast@pro-spectus.com. Find more PRO-spectus email formats with LeadIQ.

When was PRO-spectus founded?

Minus sign iconPlus sign icon
PRO-spectus was founded in 2008.
PRO-spectus logo

PRO-spectus

Pharmaceutical ManufacturingCalifornia, United States51-200 Employees

PRO-spectus operates in the pharmaceutical manufacturing sector and is headquartered in Huntington Beach, California, with a workforce of about 51 to 200 employees. The company serves pharmaceutical, medical device, and diagnostic firms by providing services that include market access, patient support, reimbursement support, and policy strategy to expand access to specialized products across the continuum of care. A core focus is translating complexity into accessible products, leveraging a team of market access and patient support professionals along with technology to address the evolving healthcare landscape. In 2024, Shore Capital Partners acquired PRO-spectus, and in January 2025 Amy Madden was appointed as Chief People & Culture Officer. The business reports annual revenue in the range of $100 million to $250 million.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2008
Employees
51-200

Section iconFunding & Financials

  • $100M - $250M

    PRO-spectus's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.